Pharmaceuticals, Biotechnology and Life Sciences
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab)…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
CAMBRIDGE, England–(BUSINESS WIRE)–#FAIRdata–Genestack, a global player in life science R&D informatics, today announced the launch of Omics Data Manager, an…
ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces…
– Zai Lab to Lead the Development and Commercialization of Ripretinib in Greater China – – Deciphera To Receive $20…
KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma…
RMAT designation follows positive Phase 2 proof-of-concept data published in the Journal of Clinical Oncology (JCO) for Viralym-M, an allogeneic,…
DUBLIN–(BUSINESS WIRE)–The “Global Genetic Disorders Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global…
TrialResults.com helps lead the way in assisting clinical trial sponsors to #BeTransparent AMSTERDAM & CANTON, Mich.–(BUSINESS WIRE)–#BeTransparent–TrialAssure® – a leading,…
DUBLIN–(BUSINESS WIRE)–The “Global Obesity Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Obesity Pipeline Highlights…